等待开盘 07-29 09:30:00 美东时间
+0.004
+0.01%
An update from Augmentum Fintech PLC ( ($GB:AUGM) ) is now available. Augmentum...
07-24 17:52
Augmentum Fintech PLC ( ($GB:AUGM) ) has shared an update. Augmentum Fintech PL...
07-01 14:28
PDUFA action date set for October 25, 2025 –– sNDA being reviewed under FDA's RTOR program –– Revumenib has the potential to become the first and only menin inhibitor approved in both R/R mNPM1 AML and R/R KMT2Ar
06-25 04:03
Augmentum Fintech PLC ( ($GB:AUGM) ) just unveiled an update. Augmentum Fintech...
06-16 14:19
26% (20/77) CR+CRh rate and 48% (37/77) ORR in efficacy-evaluable pivotal R/R mNPM1 AML population.– Robust responses observed across subgroups, regardless of co-mutations, number of prior lines of therapy, or prior
06-12 19:03
Augmentum Fintech PLC ( ($GB:AUGM) ) just unveiled an update. Augmentum Fintech...
05-21 14:22
– Primary endpoint met in R/R mNPM1 AML patients in pivotal Phase 2 portion of the AUGMENT-101 trial –– Robust remission rates in heavily pre-treated R/R mNPM1 AML population with nearly 50% overall response rate –– sNDA
05-08 04:03
Kura Oncology (NASDAQ:KURA) fell ~9% in regular trading on Thursday even as the cancer drug developer and its partner Kyowa Kirin (OTCPK:KYKOF) announced a mid-stage trial win for a menin inhibitor ca...
02-07 00:28
The latest announcement is out from Augmentum Fintech PLC ( ($GB:AUGM) ). Augme...
01-30 15:24
Augmentum Fintech PLC (GB:AUGM) has released an update. Augmentum Fintech plc a...
2024-12-03 01:18